{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:17:32Z","timestamp":1783167452898,"version":"3.54.6"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ7\/01165"],"award-info":[{"award-number":["2019\/35\/B\/NZ7\/01165"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tiv.2026.106251","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:37:42Z","timestamp":1779464262000},"page":"106251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cellular responses to morpholinated curcumin derivatives in human muscle-invasive bladder cancer cells"],"prefix":"10.1016","volume":"115","author":[{"given":"Paulina","family":"Kobylka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Murias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Bakun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Goslinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Kucinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2026.106251_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00345-025-05584-7","article-title":"Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis","volume":"43","author":"Afferi","year":"2025","journal-title":"World J. Urol."},{"key":"10.1016\/j.tiv.2026.106251_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47090716","article-title":"Revisiting curcumin in cancer therapy: recent insights into molecular mechanisms, nanoformulations, and synergistic combinations","volume":"47","author":"Akter","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.tiv.2026.106251_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1349-7006.2007.00700.x","article-title":"Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel","volume":"99","author":"Al-Abd","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tiv.2026.106251_bb0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1471-2407-14-507","article-title":"Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells","volume":"14","author":"Aparicio","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tiv.2026.106251_bb0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/1871520620666200203143803","article-title":"Therapeutic effects of curcumin against bladder Cancer: a review of possible molecular pathways","volume":"20","author":"Ashrafizadeh","year":"2020","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.tiv.2026.106251_bb0030","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00044-024-03233-z","article-title":"Morpholinated curcuminoids against urinary bladder cancer cells: synthesis and anticancer evaluation","volume":"33","author":"Bakun","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.tiv.2026.106251_bb0035","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.3390\/molecules29194536","article-title":"Quaternized curcumin derivative\u2014synthesis, physicochemical characteristics, and photocytotoxicity, including antibacterial activity after irradiation with blue light","volume":"29","author":"Bakun","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.tiv.2026.106251_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000534858","article-title":"Metastatic squamous cell carcinoma of the urinary bladder: urgent call for new therapies","volume":"108","author":"Banek","year":"2024","journal-title":"Urol. Int."},{"key":"10.1016\/j.tiv.2026.106251_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104557","article-title":"Concomitant chemotherapy in trimodal treatment of patients with muscle invasive bladder cancer: a systematic review of prospective trials","volume":"205","author":"Baudelin","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.tiv.2026.106251_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17020169","article-title":"Squamous cell bladder cancer: a rare histological variant with a demand for modern cancer therapeutics","volume":"17","author":"Bell","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.tiv.2026.106251_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00544","article-title":"Caspase-3 activation correlates with the initial mitochondrial membrane depolarization in neonatal cerebellar granule neurons","volume":"8","author":"Ben\u00edtez-Rangel","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tiv.2026.106251_bb0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s44371-025-00174-3","article-title":"A brief review on metal-curcumin complexes: synthesis approaches and their pharmaceutical applications","volume":"2","author":"Bhagat","year":"2025","journal-title":"Discov. Chem."},{"key":"10.1016\/j.tiv.2026.106251_bb0065","first-page":"e934116-1","article-title":"A review of the role of hypoxia in radioresistance in cancer therapy","volume":"27","author":"Boulefour","year":"2021","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.tiv.2026.106251_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.tiv.2026.106251_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.yao.2024.12.006","article-title":"Bladder-sparing approaches in muscle invasive bladder Cancer","volume":"5","author":"Carsel","year":"2025","journal-title":"Advances in Oncology"},{"key":"10.1016\/j.tiv.2026.106251_bb0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tiv.2026.106251_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14440\/bladder.2017.570","article-title":"Emetine reduces the effective dose of cisplatin or carboplatin required to inhibit bladder cancer cell proliferation","volume":"4","author":"Davidson","year":"2017","journal-title":"Bladder"},{"key":"10.1016\/j.tiv.2026.106251_bb0090","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0002-9440(10)64291-5","article-title":"Early necrotic DNA degradation","volume":"162","author":"Didenko","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tiv.2026.106251_bb0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.euf.2023.01.023","article-title":"Which patients to consider for bladder preservation after a complete response to neoadjuvant chemotherapy","volume":"9","author":"Egger","year":"2023","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.tiv.2026.106251_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.9937","article-title":"Cytotoxic, chemosensitizing and radiosensitizing effects of curcumin based on thioredoxin system inhibition in breast cancer cells: 2D vs. 3D cell culture system","volume":"21","author":"El Feky","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.tiv.2026.106251_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12935-023-03069-4","article-title":"Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics","volume":"23","author":"Farouk","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tiv.2026.106251_bb0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.24.00340","article-title":"Adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma: expanded efficacy from CheckMate 274","volume":"43","author":"Galsky","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tiv.2026.106251_bb0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jnutbio.2014.06.009","article-title":"Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program","volume":"25","author":"Ghosh","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.tiv.2026.106251_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41585-022-00693-z","article-title":"Health-related quality of life after curative treatment for muscle-invasive bladder cancer","volume":"20","author":"Grobet-Jeandin","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tiv.2026.106251_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/humu\/5947612","article-title":"FLLL31 induces apoptosis via the FOXO4\/BCL6 axis to inhibit bladder cancer progression","volume":"2025","author":"Han","year":"2025","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tiv.2026.106251_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120984","article-title":"Curcumin in the treatment of urological cancers: therapeutic targets, challenges and prospects","volume":"309","author":"Hashemi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2026.106251_bb0135","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/08923973.2024.2402338","article-title":"Clinical features, treatment, and outcome of nivolumab-induced cholangitis","volume":"46","author":"He","year":"2024","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.tiv.2026.106251_bb0140","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1021\/acsomega.2c07326","article-title":"Curcumin formulations for better bioavailability: what we learned from clinical trials thus far?","volume":"8","author":"Hegde","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.tiv.2026.106251_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012488","article-title":"Response of the urothelial carcinoma cell lines to cisplatin","volume":"23","author":"Hol\u00ed\u010dkov\u00e1","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106251_bb0150","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.tiv.2026.106251_bb0155","article-title":"A nomogram for predicting overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy: a retrospective cohort study","volume":"15","author":"Huang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tiv.2026.106251_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116034","article-title":"Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: molecular signaling pathway-based approaches and future perspectives","volume":"170","author":"Islam","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tiv.2026.106251_bb0165","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10495-022-01735-y","article-title":"Programmed cell death detection methods: a systematic review and a categorical comparison","volume":"27","author":"Kari","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.tiv.2026.106251_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/molecules30020295","article-title":"Insights into the mode of action of novel Morpholinated curcumin derivatives exhibiting potent antitumor activity in bladder Cancer cells in vitro","volume":"30","author":"Kobylka","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.tiv.2026.106251_bb0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbagen.2007.11.016","article-title":"Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells","volume":"1780","author":"Kunwar","year":"2008","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.tiv.2026.106251_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135269","article-title":"Novel fluorocurcuminoid-BF2 complexes and their unlocked counterparts as potential bladder anticancer agents \u2013 synthesis, physicochemical characterization, and in vitro anticancer activity","volume":"1283","author":"Ku\u017ami\u0144ska","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.tiv.2026.106251_bb0185","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.3390\/molecules29225321","article-title":"Curcumin derivatives in medicinal chemistry: potential applications in Cancer treatment","volume":"29","author":"Kuzminska","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.tiv.2026.106251_bb0190","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.1115035","article-title":"Caspases 3 and 7: key mediators of mitochondrial events of apoptosis","volume":"311","author":"Lakhani","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tiv.2026.106251_bb0195","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/ijms24021467","article-title":"Enhanced cytotoxic activity of PEGylated curcumin derivatives: synthesis, structure\u2013activity evaluation, and biological activity","volume":"24","author":"Lazewski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106251_bb0200","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s12033-024-01190-x","article-title":"Exploring the targets and molecular mechanisms of curcumin for the treatment of bladder Cancer based on network pharmacology, molecular docking and molecular dynamics","volume":"67","author":"Li","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.tiv.2026.106251_bb0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/bc4002008","article-title":"Click chemistry approach for imaging intracellular and intratissue distribution of curcumin and its nanoscale carrier","volume":"25","author":"Luo","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.tiv.2026.106251_bb0210","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.cdd.4400779","article-title":"Mitochondria-dependent apoptosis and cellular pH regulation","volume":"7","author":"Matsuyama","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tiv.2026.106251_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173016","article-title":"The potential for targeting G2\/M cell cycle checkpoint kinases in enhancing the efficacy of radiotherapy","volume":"16","author":"Melia","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.tiv.2026.106251_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/plants12091782","article-title":"Role of the dietary phytochemical curcumin in targeting cancer cell signalling pathways","volume":"12","author":"Mishra","year":"2023","journal-title":"Plants"},{"key":"10.1016\/j.tiv.2026.106251_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.euf.2025.12.010","article-title":"Prognostic factors of trimodal therapy for muscle-invasive bladder cancer: a systematic review and meta-analysis","author":"Miyajima","year":"2025","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.tiv.2026.106251_bb0230","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2026.106251_bb0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12935-025-04077-2","article-title":"Novel cyclic C5-curcuminoids possess anticancer activities against HeLa cervix carcinoma, HEC-1A adenocarcinoma, and T24 bladder carcinoma cells","volume":"25","author":"Pandur","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tiv.2026.106251_bb0240","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1007\/s13277-013-1604-3","article-title":"Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer","volume":"35","author":"Pinto-Leite","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.tiv.2026.106251_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/diseases13040103","article-title":"Phytochemicals as chemo-preventive and therapeutic agents against bladder Cancer: a comprehensive review","volume":"13","author":"Porfyris","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.tiv.2026.106251_bb0250","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","article-title":"Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder Cancer","volume":"391","author":"Powles","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tiv.2026.106251_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202500162","article-title":"Nature-inspired anticancer agents: the synergy of phytochemicals and synthetic Analogs (2019-2024)","volume":"22","author":"Rai","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.tiv.2026.106251_bb0260","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/cancers14122850","article-title":"Efficacy of vinflunine for patients with metastatic urothelial Cancer after immune checkpoint inhibitor Pretreatment\u2014a retrospective Multicenter analysis","volume":"14","author":"Riedel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tiv.2026.106251_bb0265","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.3390\/ijms21113761","article-title":"Curcumin\u2014a viable agent for better bladder Cancer treatment","volume":"21","author":"Rutz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106251_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.eucr.2021.101923","article-title":"Small-cell neuroendocrine tumor of the bladder: a rare disease in a low-risk woman","volume":"40","author":"Sarver","year":"2022","journal-title":"Urology Case Reports"},{"key":"10.1016\/j.tiv.2026.106251_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17162624","article-title":"Gene expression in muscle-invasive and non-muscle-invasive bladder cancer cells exposed to hypoxia","volume":"17","author":"Shabbir","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.tiv.2026.106251_bb0280","doi-asserted-by":"crossref","first-page":"0970","DOI":"10.34133\/research.0970","article-title":"Hypoxia-induced histone Lactylation drives cisplatin resistance in bladder Cancer by promoting RBM15-dependent m6A methylation of IGFBP3","volume":"8","author":"Sun","year":"2025","journal-title":"Research"},{"key":"10.1016\/j.tiv.2026.106251_bb0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tiv.2026.106251_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051033","article-title":"A review of curcumin and its derivatives as anticancer agents","volume":"20","author":"Tomeh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106251_bb0295","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tiv.2026.106251_bb0300","doi-asserted-by":"crossref","DOI":"10.1038\/srep38531","article-title":"FOXA1, GATA3 and PPAR\u0263 cooperate to drive luminal subtype in bladder Cancer: a molecular analysis of established human cell lines","volume":"6","author":"Warrick","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106251_bb0305","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10717544.2017.1309475","article-title":"Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy","volume":"24","author":"Wei","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.tiv.2026.106251_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106654","article-title":"Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin \u03b15\/\u03b21-FAK\/Src axis: a novel strategy for drug application","volume":"188","author":"Wu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tiv.2026.106251_bb0315","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.tiv.2026.106251_bb0320","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1039\/D2FO01663J","article-title":"Potential roles and molecular mechanisms of phytochemicals against cancer","volume":"13","author":"Zheng","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.tiv.2026.106251_bb0325","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41598-024-52413-9","article-title":"Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106251_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14090482","article-title":"Spatial metabolomics profiling reveals curcumin induces metabolic reprogramming in three-dimensional tumor spheroids","volume":"14","author":"Zhu","year":"2024","journal-title":"Metabolites"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:38:10Z","timestamp":1783165090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233326000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S0887233326000597"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106251","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular responses to morpholinated curcumin derivatives in human muscle-invasive bladder cancer cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106251"}}